JENBURPH latest shareholding pattern: promoter holding, FII / FPI holding, DII and mutual fund holding, public holding and number of shareholders, quarter by quarter.
As of Sep 2026, promoters held 46.62% of Jenburkt Pharmaceuticals Ltd, FIIs -, DIIs 0.03%, government - and the public 53.34%, across 7,351 shareholders.